PROCEPT BioRobotics Sets 4Q25 Earnings Call and Investor Day for February 2026
Event summary
- PROCEPT BioRobotics will report 4Q25 earnings on February 24, 2026, after market close.
- A corresponding conference call will begin at 4:30 p.m. Eastern Time.
- An in-person investor day is scheduled for February 25, 2026, at NASDAQ Headquarters in New York City.
- Live webcasts and archived recordings will be available on the company's investor relations website.
The big picture
PROCEPT BioRobotics is positioning itself for a strategic update as it navigates the competitive landscape of urology robotics. The company's focus on AI-powered solutions and its mission to revolutionize BPH treatment highlight its commitment to innovation. The upcoming earnings call and investor day will provide key insights into its financial health and growth prospects in a market impacted by approximately 40 million men in the United States suffering from BPH.
What we're watching
- Financial Performance
- How 4Q25 earnings will reflect the adoption of the HYDROS Robotic System and Aquablation therapy.
- Market Positioning
- Whether PROCEPT BioRobotics can sustain its growth trajectory in the competitive urology robotics market.
- Investor Sentiment
- The impact of the investor day on long-term investor confidence and stock performance.
Related topics